ResearcherBeckman Research InstituteNo recent work listed
Zheng Gang Zhu
Matched on ORCID iD 0000-0002-4112-5294; OpenAlex author ID A5000073737. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: 2 papers
Papers 3
- Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2021.12.281↗
- B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.814312↗
- Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells. First author DOI 10.1002/fft2.1↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianhua Yu · 3 shared papers, 2020–2022 · strength 0.34
- Paper Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancre… DOI 10.1053/j.gastro.2021.12.281↗
- Paper B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. DOI 10.3389/fonc.2022.814312↗
- Paper Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells. DOI 10.1002/fft2.1↗
- Kun‐Yu Teng · 2 shared papers, 2022 · strength 0.24
- Dechun Li · 1 shared paper, 2022 · strength 0.11
- Xin Zhao · 1 shared paper, 2022 · strength 0.11
- Songbing He · 1 shared paper, 2022 · strength 0.11
- Yunyun Xu · 1 shared paper, 2022 · strength 0.11
- Zhenyu Dai · 1 shared paper, 2022 · strength 0.11
- Vincent M. Chung · 1 shared paper, 2022 · strength 0.11
- Jian Zhou · 1 shared paper, 2022 · strength 0.11
- Pan Pan · 1 shared paper, 2020 · strength 0.10
- Mohammed Aldakkak · 1 shared paper, 2020 · strength 0.10
- Li‐Shu Wang · 1 shared paper, 2020 · strength 0.10
- Susan Tsai · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.